Skip to main content
Top
Published in: BMC Psychiatry 1/2014

Open Access 01-12-2014 | Debate

Etiological classification of depression based on the enzymes of tryptophan metabolism

Author: Katsuhiko Fukuda

Published in: BMC Psychiatry | Issue 1/2014

Login to get access

Abstract

Background

Viewed in terms of input and output, the mechanisms of depression are still akin to a black box. However, there must be main pivots for diverse types of depression. From recent therapeutic observations, both the serotonin (5-HT) and kynurenine pathways of tryptophan metabolism may be of particular importance to improved understanding of depression. Here, I propose an etiological classification of depression, based on key peripheral and central enzymes of tryptophan metabolism.

Discussion

Endogenous depression is caused by a larger genetic component than reactive depression. Besides enterochromaffin and mast cells, tryptophan hydroxylase 1 (TPH1), primarily expressed in the gastrointestinal tract, is also found in 5-hydroxytryptophan-producing cells (5-HTP cells) in normal intestinal enterocytes, which are thought to essentially shunt 5-HT production in 5-HT-producing cells. Genetic studies have reported an association between TPH1 and depression, or the responsiveness of depression to antidepressive medication. Therefore, it is possible that hypofunctional 5-HTP cells (reflecting TPH1 dysfunction) in the periphery lead to deficient brain 5-HT levels. Additionally, it has been reported that higher TPH2 expression in depressed suicides may reflect a homeostatic response to deficient 5-HT levels. Subsequently, endogenous depression may be caused by TPH1 dysfunction combined with compensatory TPH2 activation. Reactive depression results from life stresses and involves the hypothalamic-pituitary-adrenal axis, with resulting cortisol production inducing tryptophan 2,3-dioxygenase (TDO) activation. In secondary depression, caused by inflammation, infection, or oxidative stress, indoleamine 2,3-dioxygenase (IDO) is activated. In both reactive and secondary depression, the balance between 3-hydroxykynurenine (3-HK) and kynurenic acid may shift towards 3-HK production via kynurenine-3-monooxygenase (KMO) activation. By shifting the equilibrium position of key enzymes of tryptophan metabolism, the classical classification of depression can be reorganized, as below.
Peripheral classification of depression by key enzymes
  • TPH1 dysfunction
  • TDO activation
  • IDO activation
Central classification of depression by key enzymes
  • TPH2 activation
  • KMO activation

Summary

Etiological classification of depression expressed by peripheral (TPH1, TDO, IDO) and central (TPH2, KMO) enzymes of tryptophan metabolism may enable depression to be viewed as a clear box, with the inner components available for inspection and treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Copeland JR: Reactive and endogenous depressive illness and five-year outcome. J Affect Disord. 1984, 6: 153-162. 10.1016/0165-0327(84)90020-X.CrossRefPubMed Copeland JR: Reactive and endogenous depressive illness and five-year outcome. J Affect Disord. 1984, 6: 153-162. 10.1016/0165-0327(84)90020-X.CrossRefPubMed
2.
go back to reference Hardy P, Gorwood P: Impact of life events in the course of depression. Encéphale. 1993, 19: 481-489.PubMed Hardy P, Gorwood P: Impact of life events in the course of depression. Encéphale. 1993, 19: 481-489.PubMed
3.
go back to reference Maletic V, Robinson M, Oakes T, Iyengar S, Ball SG, Russell J: Neurobiology of depression: an integrated view of key findings. Int J Clin Pract. 2007, 61: 2030-2040. 10.1111/j.1742-1241.2007.01602.x.CrossRefPubMedPubMedCentral Maletic V, Robinson M, Oakes T, Iyengar S, Ball SG, Russell J: Neurobiology of depression: an integrated view of key findings. Int J Clin Pract. 2007, 61: 2030-2040. 10.1111/j.1742-1241.2007.01602.x.CrossRefPubMedPubMedCentral
4.
go back to reference Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Coryell W, Warshaw M, Maser JD: Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry. 1999, 156: 1000-1006.PubMed Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Coryell W, Warshaw M, Maser JD: Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry. 1999, 156: 1000-1006.PubMed
5.
go back to reference Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea MT, Coryell W, Warshaw M, Turvey C, Maser JD, Endicott J: Multiple recurrences of major depressive disorder. Am J Psychiatry. 2000, 157: 229-233. 10.1176/appi.ajp.157.2.229.CrossRefPubMed Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea MT, Coryell W, Warshaw M, Turvey C, Maser JD, Endicott J: Multiple recurrences of major depressive disorder. Am J Psychiatry. 2000, 157: 229-233. 10.1176/appi.ajp.157.2.229.CrossRefPubMed
6.
go back to reference Post RM: Conditioning and sensitisation in the longitudinal course of affective illness. Br J Psychiatry. 1986, 149: 191-201. 10.1192/bjp.149.2.191.CrossRefPubMed Post RM: Conditioning and sensitisation in the longitudinal course of affective illness. Br J Psychiatry. 1986, 149: 191-201. 10.1192/bjp.149.2.191.CrossRefPubMed
7.
go back to reference Kendler KS: Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the “kindling” hypothesis. Am J Psychiatry. 2000, 157: 1243-1251. 10.1176/appi.ajp.157.8.1243.CrossRefPubMed Kendler KS: Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the “kindling” hypothesis. Am J Psychiatry. 2000, 157: 1243-1251. 10.1176/appi.ajp.157.8.1243.CrossRefPubMed
8.
go back to reference Monroe SM: Life stress, the “kindling” hypothesis, and the recurrence of depression: considerations from a life stress perspective. Psychol Rev. 2005, 112: 417-445. 10.1037/0033-295X.112.2.417.CrossRefPubMed Monroe SM: Life stress, the “kindling” hypothesis, and the recurrence of depression: considerations from a life stress perspective. Psychol Rev. 2005, 112: 417-445. 10.1037/0033-295X.112.2.417.CrossRefPubMed
9.
go back to reference Kendler KS: Genetic risk, number of previous depressive episodes, and stressful life events in predicting the onset of major depression. Am J Psychiatry. 2001, 158: 582-586. 10.1176/appi.ajp.158.4.582.CrossRefPubMed Kendler KS: Genetic risk, number of previous depressive episodes, and stressful life events in predicting the onset of major depression. Am J Psychiatry. 2001, 158: 582-586. 10.1176/appi.ajp.158.4.582.CrossRefPubMed
10.
go back to reference Videbech P: Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry. 2004, 161: 1957-1966. 10.1176/appi.ajp.161.11.1957.CrossRefPubMed Videbech P: Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry. 2004, 161: 1957-1966. 10.1176/appi.ajp.161.11.1957.CrossRefPubMed
11.
go back to reference Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, N Gray A, Zarate CA, Charney DS: Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry. 2003, 53: 707-742. 10.1016/S0006-3223(03)00117-3.CrossRefPubMed Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, N Gray A, Zarate CA, Charney DS: Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry. 2003, 53: 707-742. 10.1016/S0006-3223(03)00117-3.CrossRefPubMed
12.
go back to reference de Kloet ER: Therapy insight: is there an imbalanced response of mineralcorticoid and glucocorticoid receptors in depression. Nat Clin Pract Endocrinol Metab. 2007, 3: 168-179. 10.1038/ncpendmet0403.CrossRefPubMed de Kloet ER: Therapy insight: is there an imbalanced response of mineralcorticoid and glucocorticoid receptors in depression. Nat Clin Pract Endocrinol Metab. 2007, 3: 168-179. 10.1038/ncpendmet0403.CrossRefPubMed
13.
go back to reference Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM: Neurobiology of depression. Neuron. 2002, 34: 13-25. 10.1016/S0896-6273(02)00653-0.CrossRefPubMed Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM: Neurobiology of depression. Neuron. 2002, 34: 13-25. 10.1016/S0896-6273(02)00653-0.CrossRefPubMed
14.
go back to reference Raison CL: When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry. 2003, 160: 1554-1565. 10.1176/appi.ajp.160.9.1554.CrossRefPubMed Raison CL: When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry. 2003, 160: 1554-1565. 10.1176/appi.ajp.160.9.1554.CrossRefPubMed
15.
go back to reference Raison CL: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27: 24-31. 10.1016/j.it.2005.11.006.CrossRefPubMed Raison CL: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27: 24-31. 10.1016/j.it.2005.11.006.CrossRefPubMed
16.
go back to reference Weisler-Frank J: Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences. Brain Behav Immun. 2005, 19: 104-111. 10.1016/j.bbi.2004.08.004.CrossRef Weisler-Frank J: Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences. Brain Behav Immun. 2005, 19: 104-111. 10.1016/j.bbi.2004.08.004.CrossRef
17.
go back to reference Duman RS: A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006, 59: 1116-1127. 10.1016/j.biopsych.2006.02.013.CrossRefPubMed Duman RS: A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006, 59: 1116-1127. 10.1016/j.biopsych.2006.02.013.CrossRefPubMed
18.
go back to reference Copolov DL, Rubin RT, Mander AJ, Sashidharan SP, Whitehouse AM, Blackburn IM, Freeman CP, Blackwood DH: DSM-III melancholia: do the criteria accurately and reliably distinguish endogenous pattern depression?. J Affect Disord. 1986, 10: 191-202. 10.1016/0165-0327(86)90004-2.CrossRefPubMed Copolov DL, Rubin RT, Mander AJ, Sashidharan SP, Whitehouse AM, Blackburn IM, Freeman CP, Blackwood DH: DSM-III melancholia: do the criteria accurately and reliably distinguish endogenous pattern depression?. J Affect Disord. 1986, 10: 191-202. 10.1016/0165-0327(86)90004-2.CrossRefPubMed
19.
go back to reference Wakefield JC: The DSM-5 debate over the bereavement exclusion: psychiatric diagnosis and the future of empirically supported treatment. Clin Psychol Rev. 2013, 33: 825-845. 10.1016/j.cpr.2013.03.007.CrossRefPubMed Wakefield JC: The DSM-5 debate over the bereavement exclusion: psychiatric diagnosis and the future of empirically supported treatment. Clin Psychol Rev. 2013, 33: 825-845. 10.1016/j.cpr.2013.03.007.CrossRefPubMed
20.
go back to reference Krasnov VN: Problems of current diagnosis of depression. Zh Nevrol Psikhiatr Im S S Korsakova. 2012, 112: 3-10.PubMed Krasnov VN: Problems of current diagnosis of depression. Zh Nevrol Psikhiatr Im S S Korsakova. 2012, 112: 3-10.PubMed
21.
22.
go back to reference Fountoulakis KN, Iacovides A, Nimatoudis I, Kaprinis G, Ierodiakonou C: Comparison of the diagnosis of melancholic and atypical features according to DSM-IV and somatic syndrome according to ICD-10 in patients suffering from major depression. Eur Psychiatry. 1999, 14: 426-433. 10.1016/S0924-9338(99)00225-4.CrossRefPubMed Fountoulakis KN, Iacovides A, Nimatoudis I, Kaprinis G, Ierodiakonou C: Comparison of the diagnosis of melancholic and atypical features according to DSM-IV and somatic syndrome according to ICD-10 in patients suffering from major depression. Eur Psychiatry. 1999, 14: 426-433. 10.1016/S0924-9338(99)00225-4.CrossRefPubMed
23.
go back to reference Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M: Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006, 163: 1905-1917. 10.1176/ajp.2006.163.11.1905.CrossRefPubMed Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M: Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006, 163: 1905-1917. 10.1176/ajp.2006.163.11.1905.CrossRefPubMed
24.
go back to reference Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ: Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. 2013, 170: 1134-1142. 10.1176/appi.ajp.2013.13030392.CrossRefPubMedPubMedCentral Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ: Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. 2013, 170: 1134-1142. 10.1176/appi.ajp.2013.13030392.CrossRefPubMedPubMedCentral
25.
go back to reference Papp M, Moryl E: Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. Eur J Pharmacol. 1994, 263: 1-7. 10.1016/0014-2999(94)90516-9.CrossRefPubMed Papp M, Moryl E: Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. Eur J Pharmacol. 1994, 263: 1-7. 10.1016/0014-2999(94)90516-9.CrossRefPubMed
26.
go back to reference Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H, Li XY, Aghajanian G, Duman RS: Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry. 2011, 69: 754-761. 10.1016/j.biopsych.2010.12.015.CrossRefPubMedPubMedCentral Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H, Li XY, Aghajanian G, Duman RS: Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry. 2011, 69: 754-761. 10.1016/j.biopsych.2010.12.015.CrossRefPubMedPubMedCentral
27.
go back to reference Vásquez CE, Riener R, Reynolds E, Britton GB: NMDA receptor dysregulation in chronic state: a possible mechanism underlying depression with BDNF downregulation. Neurochem Int. 2014, 14: 00211-00213. Vásquez CE, Riener R, Reynolds E, Britton GB: NMDA receptor dysregulation in chronic state: a possible mechanism underlying depression with BDNF downregulation. Neurochem Int. 2014, 14: 00211-00213.
28.
go back to reference Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM: Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology. 2008, 6: 1006-1014. 10.1016/j.neuropharm.2008.08.001.CrossRef Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM: Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology. 2008, 6: 1006-1014. 10.1016/j.neuropharm.2008.08.001.CrossRef
29.
go back to reference Melancon MO, Lorrain D, Dionne IJ: Exercise increases tryptophan availability to the brain in older men age 57–70 years. Med Sci Sports Exerc. 2012, 44: 881-887. 10.1249/MSS.0b013e31823ede8e.CrossRefPubMed Melancon MO, Lorrain D, Dionne IJ: Exercise increases tryptophan availability to the brain in older men age 57–70 years. Med Sci Sports Exerc. 2012, 44: 881-887. 10.1249/MSS.0b013e31823ede8e.CrossRefPubMed
30.
go back to reference Blumenthal JA, Babyak MA, Moore KA, Craighead WE, Herman S, Khatri P, Waugh R, Napolitano MA, Forman LM, Appelbaum M, Doraiswamy PM, Krishnan KR: Effects of exercise training on older patients with major depression. Arch Intern Med. 1999, 159: 2349-2356. 10.1001/archinte.159.19.2349.CrossRefPubMed Blumenthal JA, Babyak MA, Moore KA, Craighead WE, Herman S, Khatri P, Waugh R, Napolitano MA, Forman LM, Appelbaum M, Doraiswamy PM, Krishnan KR: Effects of exercise training on older patients with major depression. Arch Intern Med. 1999, 159: 2349-2356. 10.1001/archinte.159.19.2349.CrossRefPubMed
31.
go back to reference Craft L, Landers D: The effect of exercise on clinical depression and depression resulting from medical illness. A meta-analysis. J Sport Exerc Psychol. 1998, 20: 339-357. Craft L, Landers D: The effect of exercise on clinical depression and depression resulting from medical illness. A meta-analysis. J Sport Exerc Psychol. 1998, 20: 339-357.
32.
go back to reference Otto MW, Church TS, Craft LL, Greer TL, Smits JA, Trivedi MH: Exercise for mood and anxiety disorders. J Clin Psychiatry. 2007, 68: 669-676. 10.4088/JCP.v68n0515.CrossRefPubMed Otto MW, Church TS, Craft LL, Greer TL, Smits JA, Trivedi MH: Exercise for mood and anxiety disorders. J Clin Psychiatry. 2007, 68: 669-676. 10.4088/JCP.v68n0515.CrossRefPubMed
33.
go back to reference Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO: Exercise treatment for depression: efficacy and dose response. Am J Prev Med. 2005, 28: 1-8. 10.1016/j.amepre.2004.09.003.CrossRefPubMed Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO: Exercise treatment for depression: efficacy and dose response. Am J Prev Med. 2005, 28: 1-8. 10.1016/j.amepre.2004.09.003.CrossRefPubMed
34.
go back to reference Meyer T, Brinck U: Differential distribution of serotonin and tryptophan hydroxylase in the human gastrointestinal tract. Digestion. 1999, 60: 63-68. 10.1159/000007590.CrossRefPubMed Meyer T, Brinck U: Differential distribution of serotonin and tryptophan hydroxylase in the human gastrointestinal tract. Digestion. 1999, 60: 63-68. 10.1159/000007590.CrossRefPubMed
35.
go back to reference Nakamura K, Sato T, Ohashi A, Tsurui H, Hasegawa H: Role of a serotonin precursor in development of gut microvilli. Am J Pathol. 2008, 172: 333-344. 10.2353/ajpath.2008.070358.CrossRefPubMedPubMedCentral Nakamura K, Sato T, Ohashi A, Tsurui H, Hasegawa H: Role of a serotonin precursor in development of gut microvilli. Am J Pathol. 2008, 172: 333-344. 10.2353/ajpath.2008.070358.CrossRefPubMedPubMedCentral
36.
go back to reference Fukuda K: 5-HTP hypothesis of schizophrenia. Med Hypotheses. 2013, 82: 20-23. 10.1016/j.mehy.2013.10.026.CrossRefPubMed Fukuda K: 5-HTP hypothesis of schizophrenia. Med Hypotheses. 2013, 82: 20-23. 10.1016/j.mehy.2013.10.026.CrossRefPubMed
37.
go back to reference Grasberger H, Chang L, Shih W, Presson AP, Sayuk GS, Newberry RD, Karagiannides I, Pothoulakis C, Mayer E, Merchant JL: Identification of a functional TPH1 polymorphism associated with irritable bowel syndrome bowel habit subtypes. Am J Gastroenterol. 2013, 108: 1766-1774. 10.1038/ajg.2013.304.CrossRefPubMedPubMedCentral Grasberger H, Chang L, Shih W, Presson AP, Sayuk GS, Newberry RD, Karagiannides I, Pothoulakis C, Mayer E, Merchant JL: Identification of a functional TPH1 polymorphism associated with irritable bowel syndrome bowel habit subtypes. Am J Gastroenterol. 2013, 108: 1766-1774. 10.1038/ajg.2013.304.CrossRefPubMedPubMedCentral
38.
go back to reference Arias B, Fabbri C, Gressier F, Serretti A, Mitjans M, Gastó C, Catalán R, De Ronchi D, Fañanás L: TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression. Neuropsychobiology. 2013, 67: 41-47. 10.1159/000343388.CrossRefPubMed Arias B, Fabbri C, Gressier F, Serretti A, Mitjans M, Gastó C, Catalán R, De Ronchi D, Fañanás L: TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression. Neuropsychobiology. 2013, 67: 41-47. 10.1159/000343388.CrossRefPubMed
39.
go back to reference Koh KB, Kim CH, Choi EH, Lee YJ, Seo WY: Effect of tryptophan hydroxylase gene polymorphism on aggression in major depressive disorder and undifferentiated somatoform disorder. J Clin Psychiatr. 2012, 73: e574-e579. 10.4088/JCP.11m07342.CrossRef Koh KB, Kim CH, Choi EH, Lee YJ, Seo WY: Effect of tryptophan hydroxylase gene polymorphism on aggression in major depressive disorder and undifferentiated somatoform disorder. J Clin Psychiatr. 2012, 73: e574-e579. 10.4088/JCP.11m07342.CrossRef
40.
go back to reference Chen D, Liu F, Yang C, Liang X, Shang Q, He W, Wang Z: Association between the TPH1 A218C polymorphism and risk of mood disorders and alcohol dependence: evidence from the current studies. J Affect Disord. 2012, 138: 27-33. 10.1016/j.jad.2011.04.018.CrossRefPubMed Chen D, Liu F, Yang C, Liang X, Shang Q, He W, Wang Z: Association between the TPH1 A218C polymorphism and risk of mood disorders and alcohol dependence: evidence from the current studies. J Affect Disord. 2012, 138: 27-33. 10.1016/j.jad.2011.04.018.CrossRefPubMed
41.
go back to reference Viikki M, Kampman O, Illi A, Setälä-Soikkeli E, Anttila S, Huuhka M, Nuolivirta T, Poutanen O, Mononen N, Lehtimäki T, Leinonen E: TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response. Neurosci Lett. 2010, 468: 80-84. 10.1016/j.neulet.2009.10.069.CrossRefPubMed Viikki M, Kampman O, Illi A, Setälä-Soikkeli E, Anttila S, Huuhka M, Nuolivirta T, Poutanen O, Mononen N, Lehtimäki T, Leinonen E: TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response. Neurosci Lett. 2010, 468: 80-84. 10.1016/j.neulet.2009.10.069.CrossRefPubMed
42.
go back to reference Andre K, Kampman O, Vikki M, Ili A, Setälä-Soikkeli E, Poutanen O, Mononen N, Leinonen E, Lehtimäki T: TPH1 A218C polymorphism and temperament in major depression. BMC Psychiatry. 2013, 13: 118-10.1186/1471-244X-13-118.CrossRefPubMedPubMedCentral Andre K, Kampman O, Vikki M, Ili A, Setälä-Soikkeli E, Poutanen O, Mononen N, Leinonen E, Lehtimäki T: TPH1 A218C polymorphism and temperament in major depression. BMC Psychiatry. 2013, 13: 118-10.1186/1471-244X-13-118.CrossRefPubMedPubMedCentral
43.
go back to reference Shaw K, Turner J, Del Mar C: Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database Syst Rev. 2002, 1: CD003198-PubMed Shaw K, Turner J, Del Mar C: Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database Syst Rev. 2002, 1: CD003198-PubMed
44.
go back to reference Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, Yong ET: The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995, 43: 55-68. 10.1111/j.1365-2265.1995.tb01894.x.CrossRef Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, Yong ET: The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995, 43: 55-68. 10.1111/j.1365-2265.1995.tb01894.x.CrossRef
45.
go back to reference Bach-Mizrachi H, Underwood MD, Tin A, Ellis SP, Mann JJ, Arango V: Elevated expression of tryptophan hydroxylase-2 mRNA at the neuronal level in the dorsal and median raphe nuclei of depressed suicides. Mol Psychiatry. 2008, 13: 507-513. 10.1038/sj.mp.4002143.CrossRefPubMedPubMedCentral Bach-Mizrachi H, Underwood MD, Tin A, Ellis SP, Mann JJ, Arango V: Elevated expression of tryptophan hydroxylase-2 mRNA at the neuronal level in the dorsal and median raphe nuclei of depressed suicides. Mol Psychiatry. 2008, 13: 507-513. 10.1038/sj.mp.4002143.CrossRefPubMedPubMedCentral
46.
go back to reference Krishnadas R, Cavanagh J: Depression: an inflammatory illness?. J Neurol Neurosurg Psychiatry. 2012, 83: 495-502. 10.1136/jnnp-2011-301779.CrossRefPubMed Krishnadas R, Cavanagh J: Depression: an inflammatory illness?. J Neurol Neurosurg Psychiatry. 2012, 83: 495-502. 10.1136/jnnp-2011-301779.CrossRefPubMed
47.
go back to reference Rubin RT: Adrenal cortical activity changes in manic-depressive illness. Influence on intermediary metabolism of tryptophan. Arch Gen Psychiatry. 1967, 17: 671-679. 10.1001/archpsyc.1967.01730300031006.CrossRefPubMed Rubin RT: Adrenal cortical activity changes in manic-depressive illness. Influence on intermediary metabolism of tryptophan. Arch Gen Psychiatry. 1967, 17: 671-679. 10.1001/archpsyc.1967.01730300031006.CrossRefPubMed
48.
go back to reference Oxenkrug GF: Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later. Isr J Psychiatry Relat Sci. 2010, 47: 56-63.PubMedPubMedCentral Oxenkrug GF: Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later. Isr J Psychiatry Relat Sci. 2010, 47: 56-63.PubMedPubMedCentral
49.
go back to reference Myint AM: Kynurenines: from the perspective of major psychiatric disorders. FEBS J. 2012, 279: 1375-1385. 10.1111/j.1742-4658.2012.08551.x.CrossRefPubMed Myint AM: Kynurenines: from the perspective of major psychiatric disorders. FEBS J. 2012, 279: 1375-1385. 10.1111/j.1742-4658.2012.08551.x.CrossRefPubMed
50.
go back to reference Heyes MP, Saito K, Major EO, Milstien S, Markey SP, Vickers JH: A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain. 1993, 116: 1425-1450. 10.1093/brain/116.6.1425.CrossRefPubMed Heyes MP, Saito K, Major EO, Milstien S, Markey SP, Vickers JH: A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain. 1993, 116: 1425-1450. 10.1093/brain/116.6.1425.CrossRefPubMed
51.
go back to reference Mellor AL, Munn DH: Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?. Immunol Today. 1993, 20: 469-473. 10.1016/S0167-5699(99)01520-0.CrossRef Mellor AL, Munn DH: Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?. Immunol Today. 1993, 20: 469-473. 10.1016/S0167-5699(99)01520-0.CrossRef
52.
go back to reference Moffett JR, Blinder KL, Venkateshan CN, Namboodiri MA: Differential effects of kynurenine and tryptophan treatment on quinolinate immunoreactivity in rat lymphoid and non-lymphoid organs. Cell Tissue Res. 1998, 293: 525-534. 10.1007/s004410051145.CrossRefPubMed Moffett JR, Blinder KL, Venkateshan CN, Namboodiri MA: Differential effects of kynurenine and tryptophan treatment on quinolinate immunoreactivity in rat lymphoid and non-lymphoid organs. Cell Tissue Res. 1998, 293: 525-534. 10.1007/s004410051145.CrossRefPubMed
53.
go back to reference Moffett JR, Namboodiri MA: Tryptophan and the immune response. Immunol Cell Biol. 2003, 81: 247-265. 10.1046/j.1440-1711.2003.t01-1-01177.x.CrossRefPubMed Moffett JR, Namboodiri MA: Tryptophan and the immune response. Immunol Cell Biol. 2003, 81: 247-265. 10.1046/j.1440-1711.2003.t01-1-01177.x.CrossRefPubMed
54.
go back to reference Grant RS, Naif H, Espinosa M, Kapoor V: IDO induction in IFN-gamma activated astroglia: a role in improving cell viability during oxidative stress. Redox Rep. 2000, 5: 101-104. 10.1179/135100000101535357.CrossRefPubMed Grant RS, Naif H, Espinosa M, Kapoor V: IDO induction in IFN-gamma activated astroglia: a role in improving cell viability during oxidative stress. Redox Rep. 2000, 5: 101-104. 10.1179/135100000101535357.CrossRefPubMed
55.
go back to reference Grant RS, Kapoor V: Murine glial cells regenerate NAD, after peroxide-induced depletion, using either nicotinic acid, nicotinamide, or quinolinic acid as substrates. J Neurochem. 1998, 70: 1759-1763. 10.1046/j.1471-4159.1998.70041759.x.CrossRefPubMed Grant RS, Kapoor V: Murine glial cells regenerate NAD, after peroxide-induced depletion, using either nicotinic acid, nicotinamide, or quinolinic acid as substrates. J Neurochem. 1998, 70: 1759-1763. 10.1046/j.1471-4159.1998.70041759.x.CrossRefPubMed
56.
go back to reference Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, Markey SP: Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J. 1996, 320: 595-597.CrossRefPubMedPubMedCentral Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, Markey SP: Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J. 1996, 320: 595-597.CrossRefPubMedPubMedCentral
57.
go back to reference Miller CL, Llenos IC, Dulay JR, Barillo MM, Yolken RH, Weis S: Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiol Dis. 2004, 15: 618-629. 10.1016/j.nbd.2003.12.015.CrossRefPubMed Miller CL, Llenos IC, Dulay JR, Barillo MM, Yolken RH, Weis S: Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiol Dis. 2004, 15: 618-629. 10.1016/j.nbd.2003.12.015.CrossRefPubMed
58.
go back to reference Guillemin GJ, Smythe G, Takikawa O, Brew BJ: Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia. 2005, 49: 15-23. 10.1002/glia.20090.CrossRefPubMed Guillemin GJ, Smythe G, Takikawa O, Brew BJ: Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia. 2005, 49: 15-23. 10.1002/glia.20090.CrossRefPubMed
59.
go back to reference Guillemin GJ, Kerr SJ, Smythe GA, Smith DG, Kapoor V, Armati PJ, Croitoru J, Brew BJ: Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J Neurochem. 2001, 78: 842-853. 10.1046/j.1471-4159.2001.00498.x.CrossRefPubMed Guillemin GJ, Kerr SJ, Smythe GA, Smith DG, Kapoor V, Armati PJ, Croitoru J, Brew BJ: Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J Neurochem. 2001, 78: 842-853. 10.1046/j.1471-4159.2001.00498.x.CrossRefPubMed
60.
go back to reference Guillemin GJ, Smith DG, Kerr SJ, Smythe GA, Kapoor V, Armati PJ, Brew BJ: Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis. Redox Rep. 2000, 5: 108-111. 10.1179/135100000101535375.CrossRefPubMed Guillemin GJ, Smith DG, Kerr SJ, Smythe GA, Kapoor V, Armati PJ, Brew BJ: Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis. Redox Rep. 2000, 5: 108-111. 10.1179/135100000101535375.CrossRefPubMed
61.
go back to reference Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG, Sarnyai Z, Mawrin C, Brisch R, Bielau H, zu Meyer Schwabedissen L, Bogerts B, Myint AM: Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?. J Neuroinflammation. 2011, 8: 94-10.1186/1742-2094-8-94.CrossRefPubMedPubMedCentral Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG, Sarnyai Z, Mawrin C, Brisch R, Bielau H, zu Meyer Schwabedissen L, Bogerts B, Myint AM: Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?. J Neuroinflammation. 2011, 8: 94-10.1186/1742-2094-8-94.CrossRefPubMedPubMedCentral
62.
go back to reference Appel E, Kolman O, Kazimirsky G, Blumberg PM, Brodie C: Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli. NeuroReport. 1997, 8: 3309-3312. 10.1097/00001756-199710200-00023.CrossRefPubMed Appel E, Kolman O, Kazimirsky G, Blumberg PM, Brodie C: Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli. NeuroReport. 1997, 8: 3309-3312. 10.1097/00001756-199710200-00023.CrossRefPubMed
63.
go back to reference Tsiouris JA: Metabolic depression in hibernation and major depression: an explanatory theory and an animal model of depression. Med Hypotheses. 2005, 65: 829-840. 10.1016/j.mehy.2005.05.044.CrossRefPubMed Tsiouris JA: Metabolic depression in hibernation and major depression: an explanatory theory and an animal model of depression. Med Hypotheses. 2005, 65: 829-840. 10.1016/j.mehy.2005.05.044.CrossRefPubMed
64.
go back to reference Kraepelin E: Manic-Depressive Insanity and Paranoia. RN Robertson (Trans). 1921, E & S Livingstone, Edinburgh, U K Kraepelin E: Manic-Depressive Insanity and Paranoia. RN Robertson (Trans). 1921, E & S Livingstone, Edinburgh, U K
65.
go back to reference Wiener N: Cybernetics, or Communication and Control in the Animal and the Machine. 1948, MIT Press, Cambridge Wiener N: Cybernetics, or Communication and Control in the Animal and the Machine. 1948, MIT Press, Cambridge
66.
go back to reference Gross BA, Mindea SA, Pick AJ, Chandler JP, Batjer HH: Medical management of Cushing disease. Neurosurg Focus. 2007, 23: E10-PubMed Gross BA, Mindea SA, Pick AJ, Chandler JP, Batjer HH: Medical management of Cushing disease. Neurosurg Focus. 2007, 23: E10-PubMed
Metadata
Title
Etiological classification of depression based on the enzymes of tryptophan metabolism
Author
Katsuhiko Fukuda
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2014
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-014-0372-y

Other articles of this Issue 1/2014

BMC Psychiatry 1/2014 Go to the issue